Xeris Biopharma Holdings Inc (XERS) Has Fallen -7.24%, Becoming A Losing Stock For Investors
Xeris Biopharma Holdings Inc (NASDAQ:XERS) has a beta value of 0.73 and has seen 2.17 million shares traded in the recent trading session. The company,
Xeris Biopharma Holdings Inc (NASDAQ:XERS) has a beta value of 0.73 and has seen 2.17 million shares traded in the recent trading session. The company,
In the last trading session, 2.64 million Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares changed hands as the company’s beta touched 0.69. With the company’s per
In last trading session, Xeris Biopharma Holdings Inc (NASDAQ:XERS) saw 1.73 million shares changing hands with its beta currently measuring 0.68. Company’s recent per share
Xeris Biopharma Holdings Inc (NASDAQ:XERS) has a beta value of 0.69 and has seen 1.28 million shares traded in the recent trading session. The company,
In the last trading session, 2.75 million shares of the Xeris Biopharma Holdings Inc (NASDAQ:XERS) were traded, and its beta was 0.69. Most recently the
In the last trading session, 1.7 million Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares changed hands as the company’s beta touched 0.93. With the company’s per
© 2024, Powered by Smart TechOne